Carillon Tower Advisers’s Nektar Therapeutics NKTR Stock Holding History

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Shares Change %	Capital Flow	Portfolio Weight	Portfolio Position
2018 Q4	–	Sell	-21,185	Closed	-$19.4M	–	469
2018 Q3	$19.4M	Sell	21,185 -46,635	-69%	-$42.6M	0.14%	240
2018 Q2	$49.7M	Buy	67,820 +19,792	+41%	+$14.5M	0.39%	80
2018 Q1	$71.2M	Hold	48,028	–	–	0.55%	34
2017 Q4	$43K	Buy	+48,028	New	+$43K	0.46%	68